Welcome to Season 2 of BioBoss

Dec. 31, 2019 Season: 2 Duration: 00:52 Episode: 1

BioBoss host John Simboli welcomes you to Season 2!

John Simboli: 0:00

Thanks, BioBoss subscribers around the world for making Season 1 of the podcast a success. And thanks to the biopharma founders and CEOs whose insights are the foundation of BioBoss. When I launched BioBoss in January, 2019 my goal was to give subscribers a seat at the table—an opportunity to listen in on my conversations with biopharma leaders, to hear firsthand how they wrestle with the challenge of creating clarity out of ambiguity. In 2020 I invite BioBoss listeners to experience Season 2 of conversations with a new group of founders and CEOs. I'll also return to speak with some of my Season 1 guests to hear more from these leaders and the advances at their companies. Welcome to Season 2! I'm John Simboli. You're listening to BioBoss.

Antony Mattessich: CEO of Ocular Therape George Goldsmith: Co-Founder, CEO of Com

Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom

TandemAI

Discovery as a Service

1% Steps for Health Care Reform

Designing Better Therapeutics, Atom by Atom

Discovery as a Service

Shifting How We Think About Health Care Spending